The stem bark of Kalopanax pictus belonging to the family Araliaceae has been used in Korea as a tonic, analgesic, antiinflammatory and antidiabetic medicine. From this plant, hederagenin glycosides, syringin, liriodendrin, and coniferylaldehyde glucosides have been isolated. [1][2][3] Related to biological activities of K. pictus, it was reported that the active components on antidiabetic, 4) cytotoxic, 5) and antifungal assays 6) may be hederagenin monodesmosides. We also reported that kalopanaxsaponin B (KPB) and H (KPH) were easily metabolized by human intestinal bacteria to kalopanaxsaponin A (KPA) and kalopanaxsaponin I (KPI), resepectively.7) However, these metabolites were slowly transformed to hederagenin. KPI was slowly transformed to hederagenin via KPA. Among these compounds, the most antidiabetic compound was KPA. However, studies related to the metabolic pathway of KPI to hederagenin in the intestine, the biotransfromation of kalopanaxsaponin K (KPK) to KPA, which is an antitumor compound, 5) and their biological activities, such as antirheumatoid arthritis, are incomplete.Therefore we isolated the main components KPB, KPH, and KPK from the stem bark of K. pictus, investigated the metabolic pathway of these kalopanaxsaponins by human intestinal bacteria, and measured the antirheumatoid arthritis activity of the main metabolites. We also screened the biotransforming bacteria of KPK to the bioactive compound KPA from human intestinal bacteria.
MATERIALS AND METHODSInstrument Melting points were determined on an electrothermal digital melting point apparatus.1 H-and 13 C-NMR spectra were recorded on a Brucker-AM 500 with tetramethylsilane (TMS) as an internal standard. The TLC chromatogram of metabolites was quantitatively analyzed with a Shimadzu CS-920 TLC-scanner.